当前位置:首页 - 行情中心 - 鹭燕医药(002788) - 财务分析 - 利润表

鹭燕医药

(002788)

  

流通市值:31.16亿  总市值:31.82亿
流通股本:3.80亿   总股本:3.89亿

利润表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
一、营业总收入14,775,163,931.0910,024,249,628.074,841,503,352.5719,462,501,277.53
营业收入14,775,163,931.0910,024,249,628.074,841,503,352.5719,462,501,277.53
二、营业总成本14,436,462,358.369,784,261,876.824,728,514,286.9718,945,363,052.91
营业成本13,687,313,351.769,281,898,532.664,479,132,701.8617,947,344,516.37
税金及附加30,156,025.9419,856,817.969,964,092.442,264,325.67
销售费用325,351,295.64218,382,883.09105,494,333.6432,773,121.42
管理费用223,741,639.55151,490,029.6875,262,608.43298,781,685.4
研发费用2,835,211.851,938,212.92769,300.64,146,496.57
财务费用167,064,833.62110,695,400.5157,891,250.08220,052,907.48
其中:利息费用150,996,843.31101,437,599.5751,017,218.41219,103,960.98
其中:利息收入3,655,873.983,750,347.371,248,207.753,858,412.86
加:投资收益-4,851,615.76-1,664,819.49-2,582,938.01-6,920,275.57
资产处置收益-116,290.43-151,558.88-17,213.72126,686.34
资产减值损失(新)-579,622.77-328,601.49-109,239.1-3,129,035.42
信用减值损失(新)-18,282,400.98-10,937,885.18-12,016,357.23-49,298,321.82
其他收益7,575,040.795,577,202.452,998,655.978,026,964.2
营业利润平衡项目0000
四、营业利润322,446,683.58232,482,088.66101,261,973.51465,944,242.35
加:营业外收入1,227,111.091,167,601.26170,344.624,007,852.75
减:营业外支出932,762.63651,055.79211,602.93,941,682.7
利润总额平衡项目0000
五、利润总额322,741,032.04232,998,634.13101,220,715.23466,010,412.4
减:所得税费用63,681,716.7542,902,743.0322,620,215.67115,036,059.55
六、净利润259,059,315.29190,095,891.178,600,499.56350,974,352.85
持续经营净利润259,059,315.29190,095,891.178,600,499.56350,974,352.85
归属于母公司股东的净利润261,975,916.42189,013,659.4679,861,688.2345,155,498.99
少数股东损益-2,916,601.131,082,231.64-1,261,188.645,818,853.86
(一)基本每股收益0.670.490.210.89
八、其他综合收益1,216,025.571,335,862.82-441,714.343,320,155.92
归属于母公司股东的其他综合收益1,216,025.571,335,862.82-441,714.343,320,155.92
九、综合收益总额260,275,340.86191,431,753.9278,158,785.22354,294,508.77
归属于母公司股东的综合收益总额263,191,941.99190,349,522.2879,419,973.86348,475,654.91
归属于少数股东的综合收益总额-2,916,601.131,082,231.64-1,261,188.645,818,853.86
公告日期2023-10-242023-08-082023-04-182023-04-18
审计意见(境内)标准无保留意见
TOP↑